Document Type
Article
Publication Date
8-20-2021
Publication Title
Nat Commun
Keywords
JGM, Animals, Base Sequence, Cytotoxicity, Immunologic, DNA-Binding Proteins, Diabetes Mellitus, Type 1, Disease Progression, Female, Humans, Immunity, Inflammation, Insulin-Secreting Cells, Mice, Inbred C57BL, Mice, Inbred NOD, Proto-Oncogene Proteins, T-Lymphocytes, Transcription, Genetic
JAX Source
Nat Commun 2021 Aug 20; 12(1):5074
Volume
12
Issue
1
First Page
5074
Last Page
5074
ISSN
2041-1723
PMID
34417463
DOI
https://doi.org/10.1038/s41467-021-25367-z
Abstract
β cells may participate and contribute to their own demise during Type 1 diabetes (T1D). Here we report a role of their expression of Tet2 in regulating immune killing. Tet2 is induced in murine and human β cells with inflammation but its expression is reduced in surviving β cells. Tet2-KO mice that receive WT bone marrow transplants develop insulitis but not diabetes and islet infiltrates do not eliminate β cells even though immune cells from the mice can transfer diabetes to NOD/scid recipients. Tet2-KO recipients are protected from transfer of disease by diabetogenic immune cells.Tet2-KO β cells show reduced expression of IFNγ-induced inflammatory genes that are needed to activate diabetogenic T cells. Here we show that Tet2 regulates pathologic interactions between β cells and immune cells and controls damaging inflammatory pathways. Our data suggests that eliminating TET2 in β cells may reduce activating pathologic immune cells and killing of β cells.
Recommended Citation
Rui J,
Deng S,
Perdigoto A,
Ponath G,
Kursawe R,
Lawlor N,
Sumida T,
Levine-Ritterman M,
Stitzel ML,
Pitt D,
Lu J,
Herold K.
Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes. Nat Commun 2021 Aug 20; 12(1):5074
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License.